Research ArticleAccepted Article
Domains to be considered for the core outcome set of axial spondyloarthritis: results from a 3-round Delphi survey
Anne Boel, Victoria Navarro-Compán, Annelies Boonen, Philip Mease, Uta Kiltz, Maxime Dougados, Robert Landewé and Désirée van der Heijde
The Journal of Rheumatology August 2021, jrheum.210206; DOI: https://doi.org/10.3899/jrheum.210206
Anne Boel
Rheumatology Department, Leiden University Medical Centre, Leiden, the Netherlands; Rheumatology Department, University Hospital La Paz, IdiPaz, Madrid, Spain; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, Maastricht, The Netherlands; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands; Rheumatology, Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, Washington, USA; Rheumatology, Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Herne, Germany; Rheumatology Department, - Hôpital Cochin. Assistance Publique - Hôpitaux de Paris; INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France; Rheumatology Department, Zuyderland Medical Center Heerlen, Heerlen, The Netherlands; Rheumatology, Amsterdam Rheumatology Center, AMC, Amsterdam, The Netherlands. Funding The Assessment of Spondyloarthritis international Society (ASAS) funded Anne Boel and Victoria Navarro-Compán to work on the project to update the core outcome set. Correspondence to: Anne Boel, Department of Rheumatology, Leiden University Medical Centre, P.O. Box 9600 , 2300 RC Leiden, The Netherlands. a.h.e.m.boel@lumc.nl
Victoria Navarro-Compán
Rheumatology Department, Leiden University Medical Centre, Leiden, the Netherlands; Rheumatology Department, University Hospital La Paz, IdiPaz, Madrid, Spain; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, Maastricht, The Netherlands; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands; Rheumatology, Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, Washington, USA; Rheumatology, Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Herne, Germany; Rheumatology Department, - Hôpital Cochin. Assistance Publique - Hôpitaux de Paris; INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France; Rheumatology Department, Zuyderland Medical Center Heerlen, Heerlen, The Netherlands; Rheumatology, Amsterdam Rheumatology Center, AMC, Amsterdam, The Netherlands. Funding The Assessment of Spondyloarthritis international Society (ASAS) funded Anne Boel and Victoria Navarro-Compán to work on the project to update the core outcome set. Correspondence to: Anne Boel, Department of Rheumatology, Leiden University Medical Centre, P.O. Box 9600 , 2300 RC Leiden, The Netherlands. a.h.e.m.boel@lumc.nl
Annelies Boonen
Rheumatology Department, Leiden University Medical Centre, Leiden, the Netherlands; Rheumatology Department, University Hospital La Paz, IdiPaz, Madrid, Spain; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, Maastricht, The Netherlands; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands; Rheumatology, Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, Washington, USA; Rheumatology, Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Herne, Germany; Rheumatology Department, - Hôpital Cochin. Assistance Publique - Hôpitaux de Paris; INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France; Rheumatology Department, Zuyderland Medical Center Heerlen, Heerlen, The Netherlands; Rheumatology, Amsterdam Rheumatology Center, AMC, Amsterdam, The Netherlands. Funding The Assessment of Spondyloarthritis international Society (ASAS) funded Anne Boel and Victoria Navarro-Compán to work on the project to update the core outcome set. Correspondence to: Anne Boel, Department of Rheumatology, Leiden University Medical Centre, P.O. Box 9600 , 2300 RC Leiden, The Netherlands. a.h.e.m.boel@lumc.nl
Philip Mease
Rheumatology Department, Leiden University Medical Centre, Leiden, the Netherlands; Rheumatology Department, University Hospital La Paz, IdiPaz, Madrid, Spain; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, Maastricht, The Netherlands; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands; Rheumatology, Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, Washington, USA; Rheumatology, Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Herne, Germany; Rheumatology Department, - Hôpital Cochin. Assistance Publique - Hôpitaux de Paris; INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France; Rheumatology Department, Zuyderland Medical Center Heerlen, Heerlen, The Netherlands; Rheumatology, Amsterdam Rheumatology Center, AMC, Amsterdam, The Netherlands. Funding The Assessment of Spondyloarthritis international Society (ASAS) funded Anne Boel and Victoria Navarro-Compán to work on the project to update the core outcome set. Correspondence to: Anne Boel, Department of Rheumatology, Leiden University Medical Centre, P.O. Box 9600 , 2300 RC Leiden, The Netherlands. a.h.e.m.boel@lumc.nl
Uta Kiltz
Rheumatology Department, Leiden University Medical Centre, Leiden, the Netherlands; Rheumatology Department, University Hospital La Paz, IdiPaz, Madrid, Spain; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, Maastricht, The Netherlands; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands; Rheumatology, Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, Washington, USA; Rheumatology, Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Herne, Germany; Rheumatology Department, - Hôpital Cochin. Assistance Publique - Hôpitaux de Paris; INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France; Rheumatology Department, Zuyderland Medical Center Heerlen, Heerlen, The Netherlands; Rheumatology, Amsterdam Rheumatology Center, AMC, Amsterdam, The Netherlands. Funding The Assessment of Spondyloarthritis international Society (ASAS) funded Anne Boel and Victoria Navarro-Compán to work on the project to update the core outcome set. Correspondence to: Anne Boel, Department of Rheumatology, Leiden University Medical Centre, P.O. Box 9600 , 2300 RC Leiden, The Netherlands. a.h.e.m.boel@lumc.nl
Maxime Dougados
Rheumatology Department, Leiden University Medical Centre, Leiden, the Netherlands; Rheumatology Department, University Hospital La Paz, IdiPaz, Madrid, Spain; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, Maastricht, The Netherlands; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands; Rheumatology, Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, Washington, USA; Rheumatology, Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Herne, Germany; Rheumatology Department, - Hôpital Cochin. Assistance Publique - Hôpitaux de Paris; INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France; Rheumatology Department, Zuyderland Medical Center Heerlen, Heerlen, The Netherlands; Rheumatology, Amsterdam Rheumatology Center, AMC, Amsterdam, The Netherlands. Funding The Assessment of Spondyloarthritis international Society (ASAS) funded Anne Boel and Victoria Navarro-Compán to work on the project to update the core outcome set. Correspondence to: Anne Boel, Department of Rheumatology, Leiden University Medical Centre, P.O. Box 9600 , 2300 RC Leiden, The Netherlands. a.h.e.m.boel@lumc.nl
Robert Landewé
Rheumatology Department, Leiden University Medical Centre, Leiden, the Netherlands; Rheumatology Department, University Hospital La Paz, IdiPaz, Madrid, Spain; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, Maastricht, The Netherlands; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands; Rheumatology, Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, Washington, USA; Rheumatology, Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Herne, Germany; Rheumatology Department, - Hôpital Cochin. Assistance Publique - Hôpitaux de Paris; INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France; Rheumatology Department, Zuyderland Medical Center Heerlen, Heerlen, The Netherlands; Rheumatology, Amsterdam Rheumatology Center, AMC, Amsterdam, The Netherlands. Funding The Assessment of Spondyloarthritis international Society (ASAS) funded Anne Boel and Victoria Navarro-Compán to work on the project to update the core outcome set. Correspondence to: Anne Boel, Department of Rheumatology, Leiden University Medical Centre, P.O. Box 9600 , 2300 RC Leiden, The Netherlands. a.h.e.m.boel@lumc.nl
Désirée van der Heijde
Rheumatology Department, Leiden University Medical Centre, Leiden, the Netherlands; Rheumatology Department, University Hospital La Paz, IdiPaz, Madrid, Spain; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre, Maastricht, The Netherlands; Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands; Rheumatology, Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, Washington, USA; Rheumatology, Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Herne, Germany; Rheumatology Department, - Hôpital Cochin. Assistance Publique - Hôpitaux de Paris; INSERM (U1153): Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France; Rheumatology Department, Zuyderland Medical Center Heerlen, Heerlen, The Netherlands; Rheumatology, Amsterdam Rheumatology Center, AMC, Amsterdam, The Netherlands. Funding The Assessment of Spondyloarthritis international Society (ASAS) funded Anne Boel and Victoria Navarro-Compán to work on the project to update the core outcome set. Correspondence to: Anne Boel, Department of Rheumatology, Leiden University Medical Centre, P.O. Box 9600 , 2300 RC Leiden, The Netherlands. a.h.e.m.boel@lumc.nl
Article Figures & Data
Additional Files
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Accepted manuscript
Domains to be considered for the core outcome set of axial spondyloarthritis: results from a 3-round Delphi survey
Anne Boel, Victoria Navarro-Compán, Annelies Boonen, Philip Mease, Uta Kiltz, Maxime Dougados, Robert Landewé, Désirée van der Heijde
The Journal of Rheumatology Aug 2021, jrheum.210206; DOI: 10.3899/jrheum.210206
Accepted manuscript
Domains to be considered for the core outcome set of axial spondyloarthritis: results from a 3-round Delphi survey
Anne Boel, Victoria Navarro-Compán, Annelies Boonen, Philip Mease, Uta Kiltz, Maxime Dougados, Robert Landewé, Désirée van der Heijde
The Journal of Rheumatology Aug 2021, jrheum.210206; DOI: 10.3899/jrheum.210206